Transgenomic, Inc. (TBIO) - Medical Equipment - Deals and Alliances Profile

Date: November 3, 2015
Pages: 71
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: T3CEAB02BD5EN
Leaflet:

Download PDF Leaflet

Transgenomic, Inc. (TBIO) - Medical Equipment - Deals and Alliances Profile
Summary

Transgenomic, Inc. (Transgenomic) is a biotechnology company that offers medicine for detection and treatment of cancer and inherited diseases. The company’s products include ICEme Kits, and genetic assays and platforms. Its offers genetic assays and platforms such as chromatography, hanabi cytogenetic systems, genetic analysis kits, PCR reagents, tissue microarray platforms and WAVE DHPLC systems. Transgenomic provides specimen collection kits which include cardiology kits, neurology kits, oncology kits, pharmacogenomic kits, scoliscore AIS prognostic kits and Whole Exome sequencing kits. The company offers patient testing services for cardiology, neurology, mitochondrial disorders and oncology. Transgenomic is headquartered in Omaha, Nebraska, the US.

Transgenomic, Inc. (TBIO) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Transgenomic, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment Deals By Type, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment, Deals By Market, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment, Deal Details
Asset Purchase
Transgenomic Completes Acquisition Of Rights To Scoliscore AIS Prognostic Test From Axial Biotech For US$4 Million
Partnerships
University of Melbourne Enters into Licensing Agreement with Transgenomic
Transgenomic Expands Licensing Agreement with Dana-Farber Cancer Institute for Multiplexed Ice cold-PCR Technlogy
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test
Transgenomic Expands Exclusive Licensing Agreement With Dana-Farber Cancer Institute
Transgenomic Enters Into Licensing Agreement With IntegraGen
Transgenomic To Enter Into Licensing Agreement With Gene Solutions
Transgenomic Signs Exclusive Licensing Agreement With Dana-Farber Cancer Institute
Transgenomic Signs An Agreement With Power3 Medical Products
Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio
Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test
Transgenomic Enters Into Distribution Agreement With ScreenCell
Transgenomic Enters Into Distribution Agreement With A. Menarini Diagnostics
Transgenomic Enters Into Co-Development Agreement With Key Genomics
Transgenomic Expands Licensing Agreement with Exiqon
Transgenomic Enters Into Licensing Agreement With Montefiore Medical
Equity Offering
Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants
Transgenomic Raises USD7 Million in Private Placement of Shares
Transgenomic Completes Private Placement Of Shares For US$8 Million
Transgenomic Completes Private Placement Of Shares For US$19 Million
Transgenomic Completes Private Placement Of Series A Convertible Preferred Stock For US$6 Million
Asset Transactions
ADSTEC to Acquire Genetic Assays & Platforms Business Unit from Transgenomic
Edge Biosystems Acquires Ion Chromatography Product Line and Related Assets from Transgenomic for USD2 Million
Integrated DNA Technologies Acquires Rights to Surveyor Mutation Detection Technology and Assets from Transgenomic for up to USD4.25 Million
Transgenomic, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Apr 22, 2015: Transgenomic to Incorporate Horizon Discovery's Genomic Reference Standards into Multiplexed ICE COLD-PCR Kits
Financial Announcements
Aug 13, 2015: Transgenomic Reports Second Quarter 2015 Financial Results
May 14, 2015: Transgenomic Reports First Quarter 2015 Financial Results
Apr 15, 2015: Transgenomic Provides Financial and Business Update
Oct 30, 2014: Transgenomic Reports Third Quarter 2014 Financial Results
Aug 06, 2014: Transgenomic Reports Second Quarter 2014 Financial Results
May 07, 2014: Transgenomic Reports First Quarter 2014 Financial Results
Mar 12, 2014: Transgenomic Reports Fourth Quarter and Fiscal Year 2013 Financial Results
Research And Development
Oct 30, 2014: Transgenomic and University of Melbourne Collaborate to Further Validate Ability of Multiplexed ICE COLD-PCR to Enable Personalized Cancer Treatment
Corporate Communications
Aug 10, 2015: Transgenomic Establishes Clinical-Commercial Advisory Board to Help Optimize Use of Multiplexed ICE COLD-PCR in Oncology
Jun 09, 2015: Transgenomic Expands Board of Directors and Executive Team
Nov 05, 2014: Transgenomic Announces Executive Management Changes
May 15, 2014: John D. Thompson Joins Transgenomic's Board of Directors
Mar 19, 2014: Dr. Michael A. Luther Joins Transgenomic's Board of Directors
Jan 16, 2014: Transgenomic Files Application for The NASDAQ Capital Market Listing and Board Approves Reverse Stock Split Ratio
Product News
Apr 23, 2015: Horizon And Transgenomic Sign OEM Agreement
Other Significant Developments
Aug 27, 2015: Transgenomic Adds Asia Distributors for Its ICEme Kits That Enable Liquid Biopsy-Based Genomics Cancer Research on Existing Platforms
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Transgenomic, Inc., Medical Equipment, Key Facts, 2014
Transgenomic, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment Deals By Type, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015
Transgenomic, Inc., Deals By Market, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment, Deals Summary, 2009 to YTD 2015
Transgenomic Completes Acquisition Of Rights To Scoliscore AIS Prognostic Test From Axial Biotech For US$4 Million
University of Melbourne Enters into Licensing Agreement with Transgenomic
Transgenomic Expands Licensing Agreement with Dana-Farber Cancer Institute for Multiplexed Ice cold-PCR Technlogy
Quest Diagnostics Enters Into Licensing Agreement With Transgenomic For Opioid Therapy Genetic Test
Transgenomic Expands Exclusive Licensing Agreement With Dana-Farber Cancer Institute
Transgenomic Enters Into Licensing Agreement With IntegraGen
Transgenomic To Enter Into Licensing Agreement With Gene Solutions
Transgenomic Signs Exclusive Licensing Agreement With Dana-Farber Cancer Institute
Transgenomic Signs An Agreement With Power3 Medical Products
Transgenomic Enters Into Co-Development Agreement With Horizon Diagnostics For Genetic Diagnostic Tests
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio
Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test
Transgenomic Enters Into Distribution Agreement With ScreenCell
Transgenomic Enters Into Distribution Agreement With A. Menarini Diagnostics
Transgenomic Enters Into Co-Development Agreement With Key Genomics
Transgenomic Expands Licensing Agreement with Exiqon
Transgenomic Enters Into Licensing Agreement With Montefiore Medical
Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants
Transgenomic Raises USD7 Million in Private Placement of Shares
Transgenomic Completes Private Placement Of Shares For US$8 Million
Transgenomic Completes Private Placement Of Shares For US$19 Million
Transgenomic Completes Private Placement Of Series A Convertible Preferred Stock For US$6 Million
ADSTEC to Acquire Genetic Assays & Platforms Business Unit from Transgenomic
Edge Biosystems Acquires Ion Chromatography Product Line and Related Assets from Transgenomic for USD2 Million
Integrated DNA Technologies Acquires Rights to Surveyor Mutation Detection Technology and Assets from Transgenomic for up to USD4.25 Million
Transgenomic, Inc., Key Competitors
Transgenomic, Inc., Key Employees
Transgenomic, Inc., Other Locations
Transgenomic, Inc., Subsidiaries

LIST OF FIGURES

Transgenomic, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment, Deals By Market, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment, Deals By Region, 2009 to YTD 2015
Transgenomic, Inc., Medical Equipment, Deals by Market, 2009 to YTD 2015
Skip to top


Ask Your Question

Transgenomic, Inc. (TBIO) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: